GFAP mutations, age at onset, and clinical subtypes in Alexander disease
about
Alexander diseaseA New Outlook on Mental Illnesses: Glial Involvement Beyond the GluePost-translational modifications of intermediate filament proteins: mechanisms and functionsAstrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder ResearchGenetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survivalAstrocyte heterogeneity in the brain: from development to diseaseA canine orthologue of the human GFAP c.716G>A (p.Arg239His) variant causes Alexander disease in a Labrador retriever.Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach.Astrocytic TDP-43 pathology in Alexander diseaseCharacterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP.Effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of Alexander disease.Alexander's disease: reassessment of a neonatal form.Identification of a novel nonsense mutation in the rod domain of GFAP that is associated with Alexander disease.Can pathoanatomical pathways of degeneration in lumbar motion segments be identified by clustering MRI findingsDisease specific therapies in leukodystrophies and leukoencephalopathies.Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease.Neurological diseases as primary gliopathies: a reassessment of neurocentrismAlexander Disease: A Novel Mutation in GFAP Leading to Epilepsia Partialis ContinuaElevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.CSF and Blood Levels of GFAP in Alexander DiseaseBeneficial effects of Nrf2 overexpression in a mouse model of Alexander disease.GFAP expression as an indicator of disease severity in mouse models of Alexander disease.Astroglia in neurological diseasesMetabolic causes of epileptic encephalopathySplice site, frameshift, and chimeric GFAP mutations in Alexander diseaseModeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes.Functional characterization of a GFAP variant of uncertain significance in an Alexander disease case within the setting of an individualized medicine clinicComposition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander DiseaseDeficits in adult neurogenesis, contextual fear conditioning, and spatial learning in a Gfap mutant mouse model of Alexander diseaseNeuroimaging and clinical features in type II (late-onset) Alexander diseaseClinicopathological features of adult-onset neuronal intranuclear inclusion disease.Autonomic dysfunction in adult-onset alexander disease: a case report and review of the literature.Emerging role of autophagy in pediatric neurodegenerative and neurometabolic diseases.Astrocyte pathology in Alexander disease causes a marked inflammatory environment.Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker.Emerging treatments for pediatric leukodystrophies.Translational potential of astrocytes in brain disorders.Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms.Unusual presentations and intrafamilial phenotypic variability in infantile onset Alexander disease.Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.
P2860
Q24633313-F57919B9-7419-49E0-BA1A-86BCBB749CD7Q26770756-B9E1D4FA-7BA1-47FE-9BAC-66305B9D4555Q27004670-015AA3D5-601B-4730-9CA3-12B6BB52DB5FQ28068029-5FB55F91-BC81-4CDC-BEC5-348F4E534CF4Q28385079-0B89F4E3-D4AF-4BA2-9973-F2A2EA8F2E43Q28390187-0CEFE80B-DEF9-4B88-9E45-886A7AD9B9E8Q30757333-913CB879-ADB9-4B36-BFDF-7E8B0EF0DF22Q31076462-10D6BAB7-E3F0-49EA-889D-655728893C34Q33575134-CB7A9D66-B6F0-4A7E-AF9D-8925EF860A02Q33888244-AA18FA10-9A20-4819-9231-D6B307958F2CQ34183917-3E8DD01C-9807-4D3C-92D8-6D69FAEE747EQ34293888-68905A65-85A6-4FCD-B0CC-A14E6A56AD09Q34705157-2E2FE129-0841-4285-ACF3-12F4ACB6A8CAQ34788196-18F10EF5-2157-4143-9B5A-5B6AFB839D47Q35328494-EFEEAB31-6271-4F5C-9198-7BB382569252Q35778386-E8E1E2B0-3006-4E05-AFF7-06F290A529B8Q35872654-39A83504-E8A0-40FB-A03D-4A4D6140B223Q35882314-021A4677-37F2-4750-9EB5-055607C3468EQ36014767-442713B5-4A4D-423E-8556-1D16D29E321AQ36154360-D275D336-B658-445D-8811-2A4E5A57AAF3Q36251679-372F850C-271C-4646-A946-448DCCDBAA90Q36706156-AC70F2A7-32D9-44CB-BC27-C4E69DD1B5E3Q36819902-2CF1E4C4-2744-48C5-B314-E2B7065A2AAAQ36908032-980169BE-F936-4FCD-B4F9-CC3A280AEC37Q36908708-F7366246-4895-4C7D-B35B-66A17C6A0D3FQ37084919-F4FD9475-07D6-48FD-A289-BC9A38F2AC88Q37247093-526962F6-2088-4EBE-828C-D4BF1ABEA66AQ37284065-FD6A742E-A108-498D-AAF6-CA80EA32F1D1Q37325408-16133943-C276-40C2-96F3-7DE885FD5D24Q37415801-40F9F285-3C39-4A23-B490-9914B40C8323Q37739875-373149D4-043D-490C-A8BB-4A4465E60A00Q38127380-5CB976FF-8AC2-40A9-B018-5A8419268745Q38156022-CC07C7E7-EB6A-4578-92D7-5FD6AB1E9177Q38458768-F4D2BDD2-C15F-4D04-819D-D21ED62EA7E6Q38480577-C0BA605E-7598-46EC-8B2A-501BBFB3E340Q38506539-6585D9F5-AE8F-4508-901C-5B5B70738260Q38589482-07C1AD9C-AD83-49FA-8ADE-6FFD03C23EDEQ39389823-B9AB0789-A939-49A1-A8A4-FB4C79F0109DQ40131425-93AA7E6E-D727-4141-86D1-189F4C9EE7B4Q41523783-D1291C40-96C0-42CE-9314-F7355D22AA41
P2860
GFAP mutations, age at onset, and clinical subtypes in Alexander disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
GFAP mutations, age at onset, and clinical subtypes in Alexander disease
@ast
GFAP mutations, age at onset, and clinical subtypes in Alexander disease
@en
type
label
GFAP mutations, age at onset, and clinical subtypes in Alexander disease
@ast
GFAP mutations, age at onset, and clinical subtypes in Alexander disease
@en
prefLabel
GFAP mutations, age at onset, and clinical subtypes in Alexander disease
@ast
GFAP mutations, age at onset, and clinical subtypes in Alexander disease
@en
P2093
P2860
P1433
P1476
GFAP mutations, age at onset, and clinical subtypes in Alexander disease
@en
P2093
A Dinopoulos
H Amartino
P2860
P304
P356
10.1212/WNL.0B013E3182309F72
P407
P577
2011-09-14T00:00:00Z